-
1
-
-
34249720998
-
Cytokines in the pathogenesis of rheumatoid arthritis
-
McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007 7 : 429 42.
-
(2007)
Nat Rev Immunol
, vol.7
, pp. 429-42
-
-
McInnes, I.B.1
Schett, G.2
-
3
-
-
0036584028
-
Development of anti-TNF therapy for rheumatoid arthritis
-
Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2002 2 : 364 71.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 364-71
-
-
Feldmann, M.1
-
4
-
-
28144441356
-
Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from north america and sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4
-
Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from north america and sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Human Genet 2005 77 : 1044 60.
-
(2005)
Am J Human Genet
, vol.77
, pp. 1044-60
-
-
Plenge, R.M.1
Padyukov, L.2
Remmers, E.F.3
Purcell, S.4
Lee, A.T.5
Karlson, E.W.6
-
5
-
-
33746940384
-
Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis
-
Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol 2006 2 : 425 33.
-
(2006)
Nat Clin Pract Rheumatol
, vol.2
, pp. 425-33
-
-
Klareskog, L.1
Padyukov, L.2
Lorentzen, J.3
Alfredsson, L.4
-
6
-
-
33645700397
-
T-cell-targeted therapies in rheumatoid arthritis
-
Weyand CM, Goronzy JJ. T-cell-targeted therapies in rheumatoid arthritis. Nat Clin Pract Rheumatol 2006 2 : 201 10.
-
(2006)
Nat Clin Pract Rheumatol
, vol.2
, pp. 201-10
-
-
Weyand, C.M.1
Goronzy, J.J.2
-
7
-
-
0032951538
-
Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent
-
Klimiuk PA, Yang H, Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol 1999 90 : 65 78.
-
(1999)
Clin Immunol
, vol.90
, pp. 65-78
-
-
Klimiuk, P.A.1
Yang, H.2
Goronzy, J.J.3
Weyand, C.M.4
-
8
-
-
0032963292
-
CD28-deficient mice are highly resistant to collagen-induced arthritis
-
Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N et al. CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 1999 162 : 203 8.
-
(1999)
J Immunol
, vol.162
, pp. 203-8
-
-
Tada, Y.1
Nagasawa, K.2
Ho, A.3
Morito, F.4
Ushiyama, O.5
Suzuki, N.6
-
9
-
-
0019955727
-
An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies
-
Duke O, Panayi GS, Janossy G, Poulter LW. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 1982 49 : 22 30.
-
(1982)
Clin Exp Immunol
, vol.49
, pp. 22-30
-
-
Duke, O.1
Panayi, G.S.2
Janossy, G.3
Poulter, L.W.4
-
10
-
-
0035879123
-
Lymphoid neogenesis in rheumatoid synovitis
-
Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001 167 : 1072 80.
-
(2001)
J Immunol
, vol.167
, pp. 1072-80
-
-
Takemura, S.1
Braun, A.2
Crowson, C.3
Kurtin, P.J.4
Cofield, R.H.5
O'Fallon, W.M.6
-
11
-
-
38349178776
-
Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice
-
Hsu H, Yang P, Wang J, Wu Q, Myers R, Chen J et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008 9 : 166 75.
-
(2008)
Nat Immunol
, vol.9
, pp. 166-75
-
-
Hsu, H.1
Yang, P.2
Wang, J.3
Wu, Q.4
Myers, R.5
Chen, J.6
-
12
-
-
0344585384
-
Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice
-
Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003 171 : 6173 7.
-
(2003)
J Immunol
, vol.171
, pp. 6173-7
-
-
Nakae, S.1
Nambu, A.2
Sudo, K.3
Iwakura, Y.4
-
13
-
-
0032939156
-
-
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
-
Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999 42 : 963 70.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 963-70
-
-
Chabaud, M.1
Durand, J.M.2
Buchs, N.3
Fossiez, F.4
Page, G.5
Frappart, L.6
-
14
-
-
0023637951
-
T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression
-
June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine- resistant interleukin 2 gene expression. Mol Cell Biol 1987 7 : 4472 81.
-
(1987)
Mol Cell Biol
, vol.7
, pp. 4472-81
-
-
June, C.H.1
Ledbetter, J.A.2
Gillespie, M.M.3
Lindsten, T.4
Thompson, C.B.5
-
15
-
-
0025963594
-
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation
-
Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991 173 : 721 30.
-
(1991)
J Exp Med
, vol.173
, pp. 721-30
-
-
Linsley, P.S.1
Brady, W.2
Grosmaire, L.3
Aruffo, A.4
Damle, N.K.5
Ledbetter, J.A.6
-
16
-
-
16244389649
-
The B7/CD28 costimulatory family in autoimmunity
-
Keir ME, Sharpe AH. The B7/CD28 costimulatory family in autoimmunity. Immunol Rev 2005 204 : 128 43.
-
(2005)
Immunol Rev
, vol.204
, pp. 128-43
-
-
Keir, M.E.1
Sharpe, A.H.2
-
17
-
-
33644967813
-
-
CTLA4Ig: Bridging the basic immunology with clinical application.
-
Bluestone JA, St. Clair E William, Turka LA. CTLA4Ig: Bridging the basic immunology with clinical application. Immunity 2006 24 : 233 8.
-
(2006)
Immunity
, vol.24
, pp. 233-8
-
-
Bluestone, J.A.1
St. Clair, E.W.2
Turka, L.A.3
-
18
-
-
0025830902
-
CTLA-4 is a second receptor for the B cell activation antigen B7
-
Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991 174 : 561 9.
-
(1991)
J Exp Med
, vol.174
, pp. 561-9
-
-
Linsley, P.S.1
Brady, W.2
Urnes, M.3
Grosmaire, L.S.4
Damle, N.K.5
Ledbetter, J.A.6
-
19
-
-
0027397169
-
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
-
Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993 177 : 165 73.
-
(1993)
J Exp Med
, vol.177
, pp. 165-73
-
-
Tan, P.1
Anasetti, C.2
Hansen, J.A.3
Melrose, J.4
Brunvand, M.5
Bradshaw, J.6
-
20
-
-
35948934705
-
Abatacept binds to the fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity
-
Davis PM, Abraham R, Xu L, Nadler SG, Suchard SJ. Abatacept binds to the fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity. J Rheumatol 2007 34 : 2204 10.
-
(2007)
J Rheumatol
, vol.34
, pp. 2204-10
-
-
Davis, P.M.1
Abraham, R.2
Xu, L.3
Nadler, S.G.4
Suchard, S.J.5
-
21
-
-
0029162499
-
Collagen-induced arthritis in the BB rat. prevention of disease by treatment with CTLA-4-ig
-
Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ. Collagen-induced arthritis in the BB rat. prevention of disease by treatment with CTLA-4-ig. J Clin Invest 1995 96 : 987 93.
-
(1995)
J Clin Invest
, vol.96
, pp. 987-93
-
-
Knoerzer, D.B.1
Karr, R.W.2
Schwartz, B.D.3
Mengle-Gaw, L.J.4
-
22
-
-
0028153996
-
B cell function in mice transgenic for mCTLA4-H gamma 1: Lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells
-
Lane P, Burdet C, Hubele S, Scheidegger D, Muller U, McConnell F et al. B cell function in mice transgenic for mCTLA4-H gamma 1: Lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J Exp Med 1994 179 : 819 30.
-
(1994)
J Exp Med
, vol.179
, pp. 819-30
-
-
Lane, P.1
Burdet, C.2
Hubele, S.3
Scheidegger, D.4
Muller, U.5
McConnell, F.6
-
23
-
-
0033135564
-
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
-
Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 1999 103 : 1243 52.
-
(1999)
J Clin Invest
, vol.103
, pp. 1243-52
-
-
Abrams, J.R.1
Lebwohl, M.G.2
Guzzo, C.A.3
Jegasothy, B.V.4
Goldfarb, M.T.5
Goffe, B.S.6
-
24
-
-
0036275436
-
Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion
-
Moreland LW, Alten R, Van den Bosch F, Appelboom T, Leon M, Emery P et al. Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum 2002 46 : 1470 9.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 1470-9
-
-
Moreland, L.W.1
Alten, R.2
Van Den Bosch, F.3
Appelboom, T.4
Leon, M.5
Emery, P.6
-
25
-
-
0242574700
-
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
-
Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003 349 : 1907 15.
-
(2003)
N Engl J Med
, vol.349
, pp. 1907-15
-
-
Kremer, J.M.1
Westhovens, R.2
Leon, M.3
Di Giorgio, E.4
Alten, R.5
Steinfeld, S.6
-
26
-
-
23644455857
-
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial
-
Kremer JM, Dougados M, Emery P, Durez P, Sibilia J, Shergy W et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005 52 : 2263 71.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 2263-71
-
-
Kremer, J.M.1
Dougados, M.2
Emery, P.3
Durez, P.4
Sibilia, J.5
Shergy, W.6
-
27
-
-
33645806121
-
Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life
-
Emery P, Kosinski M, Li T, Martin M, Williams GR, Becker JC et al. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life. J Rheumatol 2006 33 : 681 9.
-
(2006)
J Rheumatol
, vol.33
, pp. 681-9
-
-
Emery, P.1
Kosinski, M.2
Li, T.3
Martin, M.4
Williams, G.R.5
Becker, J.C.6
-
28
-
-
33745291091
-
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: A randomized trial
-
Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C et al. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: A randomized trial. Ann Intern Med 2006 144 : 865 76.
-
(2006)
Ann Intern Med
, vol.144
, pp. 865-76
-
-
Kremer, J.M.1
Genant, H.K.2
Moreland, L.W.3
Russell, A.S.4
Emery, P.5
Abud-Mendoza, C.6
-
29
-
-
42449098374
-
Results of a two-year follow-up study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
-
Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C et al. Results of a two-year follow-up study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum 2008 58 : 953 63.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 953-63
-
-
Kremer, J.M.1
Genant, H.K.2
Moreland, L.W.3
Russell, A.S.4
Emery, P.5
Abud-Mendoza, C.6
-
30
-
-
47949111861
-
Abatacept inhibits progression of structural damage in rheumatoid arthritis: Results from the long-term extension of the AIM trial
-
Genant HK, Peterfy CG, Westhovens R, Becker J, Aranda R, Vratsanos G et al. Abatacept inhibits progression of structural damage in rheumatoid arthritis: Results from the long-term extension of the AIM trial. Ann Rheum Dis 2008 67 : 1084 9.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1084-9
-
-
Genant, H.K.1
Peterfy, C.G.2
Westhovens, R.3
Becker, J.4
Aranda, R.5
Vratsanos, G.6
-
31
-
-
24944498854
-
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition
-
Genovese MC, Becker JC, Schiff M, Luggen M, Sherrer Y, Kremer J et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 2005 353 : 1114 23.
-
(2005)
N Engl J Med
, vol.353
, pp. 1114-23
-
-
Genovese, M.C.1
Becker, J.C.2
Schiff, M.3
Luggen, M.4
Sherrer, Y.5
Kremer, J.6
-
32
-
-
41849120516
-
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
-
Genovese MC, Schiff M, Luggen M, Becker J, Aranda R, Teng J et al. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. Ann Rheum Dis 2008 67 : 547 54.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 547-54
-
-
Genovese, M.C.1
Schiff, M.2
Luggen, M.3
Becker, J.4
Aranda, R.5
Teng, J.6
-
33
-
-
33749586734
-
Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial
-
(Oxford)
-
Westhovens R, Cole JC, Li T, Martin M, Maclean R, Lin P et al. Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial. Rheumatology (Oxford) 2006 45 : 1238 46.
-
(2006)
Rheumatology
, vol.45
, pp. 1238-46
-
-
Westhovens, R.1
Cole, J.C.2
Li, T.3
Martin, M.4
MacLean, R.5
Lin, P.6
-
34
-
-
47949106400
-
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: A phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
-
Schiff M, Keiserman M, Codding C, Songcharoen S, Berman A, Nayiager S et al. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: A phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Ann Rheum Dis 2008 67 : 1096 103.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1096-103
-
-
Schiff, M.1
Keiserman, M.2
Codding, C.3
Songcharoen, S.4
Berman, A.5
Nayiager, S.6
-
35
-
-
33749365296
-
Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study
-
Weinblatt M, Combe B, Covucci A, Aranda R, Becker JC, Keystone E. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study. Arthritis Rheum 2006 54 : 2807 16.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2807-16
-
-
Weinblatt, M.1
Combe, B.2
Covucci, A.3
Aranda, R.4
Becker, J.C.5
Keystone, E.6
-
36
-
-
33846853779
-
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: A randomised clinical trial
-
Weinblatt M, Schiff M, Goldman A, Kremer J, Luggen M, Li T et al. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: A randomised clinical trial. Ann Rheum Dis 2007 66 : 228 34.
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 228-34
-
-
Weinblatt, M.1
Schiff, M.2
Goldman, A.3
Kremer, J.4
Luggen, M.5
Li, T.6
|